An interventional study of BOR15001L7 and Placebo in Herpes Labialis, sponsored by Laboratoire Boreaderme Inc.. Status unknown at 1 site in Canada. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2017-03-09.
Sponsored by Laboratoire Boreaderme Inc. · Not applicable, Interventional, and Treatment
The aim of this study is to determine the safety and efficacy of a topical natural health product in comparison to placebo for the treatment of herpes labialis.
305 studies on the registry are indexed under Herpes Simplex; 31 are open to participants now.
This study's planned enrollment of 40 is below the median of 101 across 227 interventional studies indexed under Herpes Simplex.
Browse Herpes Simplex studies →Laboratoire Boreaderme Inc. is the lead sponsor of 2 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
BOR15001L7 Cream with 5% 15019L0
Other: BOR15001L7
Placebo Cream
Other: Placebo
Active cream with 5% 15019L0
Placebo Cream with 0% 15019L0
Time to healing as assessed by the investigator
Time frame: up to 10 days
This study is status unknown, as verified in Mar 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Laboratoire Boreaderme Inc.